Logo image of GIPR

GENERATION INCOME PROPERTIES (GIPR) Stock Fundamental Analysis

USA - NASDAQ:GIPR - US37149D2045 - Common Stock

1.64 USD
+0.56 (+51.89%)
Last: 10/3/2025, 8:00:01 PM
1.57 USD
-0.07 (-4.27%)
After Hours: 10/3/2025, 8:00:01 PM
Fundamental Rating

2

Overall GIPR gets a fundamental rating of 2 out of 10. We evaluated GIPR against 129 industry peers in the Diversified REITs industry. GIPR may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, GIPR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

GIPR had negative earnings in the past year.
GIPR had a positive operating cash flow in the past year.
In the past 5 years GIPR always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: GIPR reported negative operating cash flow in multiple years.
GIPR Yearly Net Income VS EBIT VS OCF VS FCFGIPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

GIPR has a Return On Assets of -9.92%. This is amonst the worse of the industry: GIPR underperforms 93.80% of its industry peers.
Industry RankSector Rank
ROA -9.92%
ROE N/A
ROIC N/A
ROA(3y)-6.22%
ROA(5y)N/A
ROE(3y)-72.16%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GIPR Yearly ROA, ROE, ROICGIPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2021 2022 2023 2024 -50 -100

1.3 Margins

GIPR has a Gross Margin of 72.94%. This is in the better half of the industry: GIPR outperforms 66.67% of its industry peers.
GIPR's Gross Margin has declined in the last couple of years.
GIPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.28%
GM growth 5Y-4.36%
GIPR Yearly Profit, Operating, Gross MarginsGIPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2021 2022 2023 2024 0 50 -50 -100

0

2. Health

2.1 Basic Checks

GIPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GIPR has more shares outstanding
Compared to 5 years ago, GIPR has more shares outstanding
The debt/assets ratio for GIPR is higher compared to a year ago.
GIPR Yearly Shares OutstandingGIPR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2021 2022 2023 2024 1M 2M 3M 4M 5M
GIPR Yearly Total Debt VS Total AssetsGIPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

GIPR has an Altman-Z score of -0.39. This is a bad value and indicates that GIPR is not financially healthy and even has some risk of bankruptcy.
GIPR has a worse Altman-Z score (-0.39) than 83.72% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.39
ROIC/WACCN/A
WACC6.34%
GIPR Yearly LT Debt VS Equity VS FCFGIPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 0.04 indicates that GIPR may have some problems paying its short term obligations.
GIPR has a Current ratio of 0.04. This is amonst the worse of the industry: GIPR underperforms 96.90% of its industry peers.
GIPR has a Quick Ratio of 0.04. This is a bad value and indicates that GIPR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.04, GIPR is not doing good in the industry: 96.90% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
GIPR Yearly Current Assets VS Current LiabilitesGIPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2021 2022 2023 2024 2M 4M 6M 8M 10M

4

3. Growth

3.1 Past

GIPR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.69%, which is quite impressive.
GIPR shows a small growth in Revenue. In the last year, the Revenue has grown by 2.33%.
The Revenue has been growing by 41.35% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)23.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-92.86%
Revenue 1Y (TTM)2.33%
Revenue growth 3Y35.78%
Revenue growth 5Y41.35%
Sales Q2Q%7.66%

3.2 Future

Based on estimates for the next years, GIPR will show a decrease in Earnings Per Share. The EPS will decrease by -6.27% on average per year.
The Revenue is expected to grow by 1.24% on average over the next years.
EPS Next Y-37.82%
EPS Next 2Y-6.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.96%
Revenue Next 2Y1.24%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GIPR Yearly Revenue VS EstimatesGIPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M
GIPR Yearly EPS VS EstimatesGIPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5 -2

0

4. Valuation

4.1 Price/Earnings Ratio

GIPR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GIPR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GIPR Price Earnings VS Forward Price EarningsGIPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

71.32% of the companies in the same industry are cheaper than GIPR, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.23
GIPR Per share dataGIPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

A cheap valuation may be justified as GIPR's earnings are expected to decrease with -6.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.27%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

GIPR has a Yearly Dividend Yield of 11.70%, which is a nice return.
Compared to an average industry Dividend Yield of 6.70, GIPR pays a better dividend. On top of this GIPR pays more dividend than 93.02% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, GIPR pays a better dividend.
Industry RankSector Rank
Dividend Yield 11.7%

5.2 History

GIPR has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
GIPR Yearly Dividends per shareGIPR Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DP0%
EPS Next 2Y-6.27%
EPS Next 3YN/A
GIPR Yearly Income VS Free CF VS DividendGIPR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2021 2022 2023 2024 0 -10M -20M -30M

GENERATION INCOME PROPERTIES

NASDAQ:GIPR (10/3/2025, 8:00:01 PM)

After market: 1.57 -0.07 (-4.27%)

1.64

+0.56 (+51.89%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-15 2025-08-15/amc
Earnings (Next)N/A N/A
Inst Owners8.49%
Inst Owner Change1.53%
Ins Owners8.9%
Ins Owner Change3.86%
Market Cap8.92M
Analysts43.33
Price TargetN/A
Short Float %7%
Short Ratio1.15
Dividend
Industry RankSector Rank
Dividend Yield 11.7%
Yearly Dividend0.33
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-43.52%
Min EPS beat(2)-80.48%
Max EPS beat(2)-6.56%
EPS beat(4)1
Avg EPS beat(4)-4.11%
Min EPS beat(4)-80.48%
Max EPS beat(4)90.44%
EPS beat(8)3
Avg EPS beat(8)-21.59%
EPS beat(12)4
Avg EPS beat(12)-23.27%
EPS beat(16)6
Avg EPS beat(16)-48.1%
Revenue beat(2)2
Avg Revenue beat(2)3.86%
Min Revenue beat(2)0.09%
Max Revenue beat(2)7.62%
Revenue beat(4)4
Avg Revenue beat(4)5.24%
Min Revenue beat(4)0.09%
Max Revenue beat(4)9.07%
Revenue beat(8)6
Avg Revenue beat(8)6.71%
Revenue beat(12)8
Avg Revenue beat(12)4.11%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-11.63%
EPS NQ rev (3m)-11.63%
EPS NY rev (1m)-26.11%
EPS NY rev (3m)-26.11%
Revenue NQ rev (1m)2.1%
Revenue NQ rev (3m)2.1%
Revenue NY rev (1m)1.57%
Revenue NY rev (3m)1.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.9
P/FCF N/A
P/OCF 32.32
P/B N/A
P/tB N/A
EV/EBITDA 17.23
EPS(TTM)-1.9
EYN/A
EPS(NY)-1.9
Fwd EYN/A
FCF(TTM)-1.01
FCFYN/A
OCF(TTM)0.05
OCFY3.09%
SpS1.82
BVpS-0.25
TBVpS-17.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.92%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 72.94%
FCFM N/A
ROA(3y)-6.22%
ROA(5y)N/A
ROE(3y)-72.16%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.28%
GM growth 5Y-4.36%
F-Score3
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 15.15
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion 6.71%
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z -0.39
F-Score3
WACC6.34%
ROIC/WACCN/A
Cap/Depr(3y)557.21%
Cap/Depr(5y)N/A
Cap/Sales(3y)244.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-92.86%
EPS Next Y-37.82%
EPS Next 2Y-6.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.33%
Revenue growth 3Y35.78%
Revenue growth 5Y41.35%
Sales Q2Q%7.66%
Revenue Next Year1.96%
Revenue Next 2Y1.24%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5597.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y53.33%
OCF growth 3YN/A
OCF growth 5YN/A